{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:30:15Z","timestamp":1791181815852,"version":"4.1.0"},"reference-count":17,"publisher":"S. Karger AG","issue":"2-3","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cerebrovasc Dis"],"published-print":{"date-parts":[[2006]]},"abstract":"<jats:p>&lt;i&gt;Background and Purpose:&lt;\/i&gt;The gene-encoding plasminogen activator inhibitor type 1 (PAI-1) has a common 4G\/5G \u2018functional\u2019 polymorphism, and people homozygous for the 4G allele have higher PAI-1 plasma concentrations. The 4G\/4G genotype is associated with increased risk of myocardial infarction but paradoxically protects against stroke. We hypothesized that this paradox may be explained via an effect of the PAI-1 polymorphism on plasma lipids. &lt;i&gt;Methods:&lt;\/i&gt; We studied 71 consecutive Italian patients referred to our Institute for first stroke or vascular cognitive impairment. PAI-1 gene 4G\/5G polymorphism, total plasma cholesterol, plasma triglycerides, sex, age, smoking, oral contraceptive use, statin therapy, hypertension, diabetes, and history of myocardial infarction were examined. &lt;i&gt;Results:&lt;\/i&gt;The 4G\/4G genotype was significantly associated with high cholesterol (p = 0.003) but not with triglycerides (p = 0.39). Adjusted odds ratios were: 5.8 for 4G\/4G vs. 4G\/5G (95% CI, 3.1\u201323.0), and 15.9 for 4G\/4G vs. 5G\/5G (95% CI, 2.4\u2013105.0). &lt;i&gt;Conclusions:&lt;\/i&gt;This finding may explain the involvement of the PAI-1 polymorphism in the clustering of atherothrombotic risk factors, and why people with the 4G\/4G genotype are at increased risk for myocardial infarction. Stroke is not so clearly related to hypercholesterolemia and other effects of the 4G\/4G genotype (perhaps increased PAI-1 expression) may protect against stroke.<\/jats:p>","DOI":"10.1159\/000093604","type":"journal-article","created":{"date-parts":[[2006,5,31]],"date-time":"2006-05-31T13:57:59Z","timestamp":1149083879000},"page":"191-195","source":"Crossref","is-referenced-by-count":23,"title":["An Effect of the PAI-1 4G\/5G Polymorphism on Cholesterol Levels May Explain Conflicting Associations with Myocardial Infarction and Stroke"],"prefix":"10.1159","volume":"22","author":[{"given":"Giorgio B.","family":"Boncoraglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Bodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rita","family":"Carriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Ciusani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio A.","family":"Parati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2006,7,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056%2FNEJM200006153422406"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161%2F01.ATV.0000107402.79771.fc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182%2Fblood-2002-07-2181"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161%2F01.STR.0000103831.56586.4F"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161%2F01.STR.0000183617.54752.69"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158%2F1078-0432.CCR-03-0198"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161%2F01.STR.24.1.35"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016%2FS0022-2143%2803%2900063-5"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159%2F000047656"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159%2F000064732"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161%2F01.STR.0000174485.10277.24"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136%2Fbmj.330.7499.1076"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161%2F01.STR.0000130461.47925.b0"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161%2F01.CIR.0000017327.69909.FF"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161%2F01.STR.0000181078.74698.b0"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038%2Fnature04226"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016%2Fj.exger.2004.03.017"}],"container-title":["Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/93604","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/93604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T03:13:58Z","timestamp":1745464438000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000093604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":17,"journal-issue":{"issue":"2-3","published-online":{"date-parts":[[2006,7,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000093604","archive":["Portico"],"relation":{},"ISSN":["1015-9770","1421-9786"],"issn-type":[{"value":"1015-9770","type":"print"},{"value":"1421-9786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}